Abstract #277: Subanalysis of the Comparative Effects of Pioglitazone and Rosiglitazone on Markers of Diabetic Dyslipidemia in Elderly Patients With Type 2 Diabetes and Dyslipidemia

Journal article

Peer reviewed

Mehmood Khan, Alfonso Perez, Ronald Goldberg, Robert Spanheimer and Scott Jacober

Endocrine practice, Vol.12, pp.18-19

2006-03

Metrics

7 Record Views

Title: Abstract #277: Subanalysis of the Comparative Effects of Pioglitazone and Rosiglitazone on Markers of Diabetic Dyslipidemia in Elderly Patients With Type 2 Diabetes and Dyslipidemia
Creators: Mehmood Khan
Alfonso Perez
Ronald Goldberg
Robert Spanheimer
Scott Jacober
Publication Details: Endocrine practice, Vol.12, pp.18-19
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI)
Language: English
Resource Type: Journal article
Record Identifier: 991031740185402976